157 related articles for article (PubMed ID: 38332530)
1. ITGBL1 promotes anoikis resistance and metastasis in human gastric cancer via the AKT/FBLN2 axis.
Shen K; Xia W; Wang K; Li J; Xu W; Liu H; Yang K; Zhu J; Wang J; Xi Q; Shi T; Li R
J Cell Mol Med; 2024 Feb; 28(4):e18113. PubMed ID: 38332530
[TBL] [Abstract][Full Text] [Related]
2. ITGBL1 promotes gastric cancer cell proliferation and invasion via Akt signal pathway.
Yin FY; Qi HP; Qiao H; Lv XH; Tan HH
Front Biosci (Landmark Ed); 2021 Jan; 26(4):682-691. PubMed ID: 33049688
[TBL] [Abstract][Full Text] [Related]
3. Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling.
Du S; Yang Z; Lu X; Yousuf S; Zhao M; Li W; Miao J; Wang X; Yu H; Zhu X; Chen H; Shi L; Xu E; Xia X; Guan W
Oncogene; 2021 Sep; 40(38):5764-5779. PubMed ID: 34341514
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of potential gastric cancer prognostic biomarker ITGBL1 associated with immune infiltration and epithelial-mesenchymal transition.
Wang Z; Fu L; Zhang J; Ge Y; Guo C; Wang R; Deng M; Wang Q; Wang Z
Biomed Eng Online; 2022 May; 21(1):30. PubMed ID: 35596183
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 contributes to anoikis resistance in human gastric cancer SGC-7901 cells via regulating Src-dependent EGFR-ITGB1 signaling.
Wang K; Zhu X; Mei D; Ding Z
J Biochem Mol Toxicol; 2018 Oct; 32(10):e22202. PubMed ID: 30088837
[TBL] [Abstract][Full Text] [Related]
6. Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis.
Ye G; Yang Q; Lei X; Zhu X; Li F; He J; Chen H; Ling R; Zhang H; Lin T; Liang Z; Liang Y; Huang H; Guo W; Deng H; Liu H; Hu Y; Yu J; Li G
Theranostics; 2020; 10(17):7545-7560. PubMed ID: 32685004
[No Abstract] [Full Text] [Related]
7. TRIM69 suppressed the anoikis resistance and metastasis of gastric cancer through ubiquitin‒proteasome-mediated degradation of PRKCD.
Sun L; Chen Y; Xia L; Wang J; Zhu J; Li J; Wang K; Shen K; Zhang D; Zhang G; Shi T; Chen W
Oncogene; 2023 Dec; 42(49):3619-3632. PubMed ID: 37864033
[TBL] [Abstract][Full Text] [Related]
8. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of ITGBL1 predicts poor prognosis and promotes chemoresistance in ovarian cancer.
Song J; Yang P; Lu J
Cancer Biomark; 2020; 27(1):51-61. PubMed ID: 31683459
[TBL] [Abstract][Full Text] [Related]
10. TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR.
Zhang T; Wang B; Su F; Gu B; Xiang L; Gao L; Zheng P; Li XM; Chen H
Int J Biol Sci; 2022; 18(11):4560-4577. PubMed ID: 35864968
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
[TBL] [Abstract][Full Text] [Related]
12. Adipocytes fuel gastric cancer omental metastasis
Tan Y; Lin K; Zhao Y; Wu Q; Chen D; Wang J; Liang Y; Li J; Hu J; Wang H; Liu Y; Zhang S; He W; Huang Q; Hu X; Yao Z; Liang B; Liao W; Shi M
Theranostics; 2018; 8(19):5452-5468. PubMed ID: 30555557
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of anoikis resistance promotes alterations in the Ras/ERK and PI3K/Akt signaling pathways and matrix remodeling in endothelial cells.
de Sousa Mesquita AP; de Araújo Lopes S; Pernambuco Filho PCA; Nader HB; Lopes CC
Apoptosis; 2017 Sep; 22(9):1116-1137. PubMed ID: 28653224
[TBL] [Abstract][Full Text] [Related]
14. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
15. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer.
Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S
Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195
[TBL] [Abstract][Full Text] [Related]
16. ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer.
Li R; Zhuang C; Jiang S; Du N; Zhao W; Tu L; Cao H; Zhang Z; Chen X
J Cancer; 2017; 8(18):3764-3773. PubMed ID: 29151964
[TBL] [Abstract][Full Text] [Related]
17. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
[TBL] [Abstract][Full Text] [Related]
18. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
[TBL] [Abstract][Full Text] [Related]
19. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X
Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856
[TBL] [Abstract][Full Text] [Related]
20. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.
Jia J; Zhang W; Liu JY; Chen G; Liu H; Zhong HY; Liu B; Cai Y; Zhang JL; Zhao YF
PLoS One; 2012; 7(12):e51549. PubMed ID: 23272116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
